INVI Invitro International Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : INVI Invitro International

INVI 0.00

Jun 30 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: rodster397 who wrote (418)	6/3/1998 2:03:00 AM
From: BigAppleBoy	Read Replies (1) of 486

Some more info from the CEO In reviewing current opportunities for INVI, Ulmer indicated that the recent increase in Department of Transportation enforcement personnel appears to have spurred more interest in Corrositexr testing in the United States; in addition, INVI's agents and partner laboratories in both Asia and Europe have developed several new business opportunities for the Company's Irritection Assay Systemr during the last year. Ulmer commented, "InVitro International has demonstrated a mental toughness and shown its ability to stay on course under difficult circumstances; we continue to believe that we are ahead of our time both with the non-animal testing core business as well as with the infant safety and identification product, Guardian DNA." He continued by saying, "with the November 1997 United Kingdom legislation preventing future new finished cosmetics from being tested on animals, there is potential for more demand for non-animal test methodologies such as INVI's Irritection Assay System in its Ocular and Dermal forms."

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next